دورية أكاديمية

Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.

التفاصيل البيبلوغرافية
العنوان: Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.
المؤلفون: Chen J; Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA., Flexner C, Liberman RG, Skipper PL, Louissaint NA, Tannenbaum SR, Hendrix CW, Fuchs EJ
المصدر: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2012 Dec 15; Vol. 61 (5), pp. 593-9.
نوع المنشور: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins, Inc., c1999-
مواضيع طبية MeSH: Adenine/*analogs & derivatives , Anti-HIV Agents/*administration & dosage , Anti-HIV Agents/*pharmacokinetics , Dideoxynucleotides/*administration & dosage , Dideoxynucleotides/*pharmacokinetics , Organophosphonates/*administration & dosage , Organophosphonates/*pharmacokinetics , Thymine Nucleotides/*administration & dosage , Thymine Nucleotides/*pharmacokinetics , Zidovudine/*analogs & derivatives, Adenine/administration & dosage ; Adenine/blood ; Adenine/pharmacokinetics ; Adult ; Anti-HIV Agents/blood ; Biological Availability ; CD4-Positive T-Lymphocytes/metabolism ; Carbon Radioisotopes ; Dideoxynucleotides/blood ; Female ; Humans ; Male ; Mass Spectrometry ; Middle Aged ; Organophosphonates/blood ; Phosphorylation ; Reverse Transcriptase Inhibitors/administration & dosage ; Reverse Transcriptase Inhibitors/blood ; Reverse Transcriptase Inhibitors/pharmacokinetics ; Tenofovir ; Thymine Nucleotides/blood ; Zidovudine/administration & dosage ; Zidovudine/blood ; Zidovudine/pharmacokinetics
مستخلص: Objective: Phase 0 studies can provide initial pharmacokinetics (PKs) data in humans and help to facilitate early drug development, but their predictive value for standard dosing is controversial. To evaluate the prediction of microdosing for active intracellular drug metabolites, we compared the PK profile of 2 antiretroviral drugs, zidovudine (ZDV) and tenofovir (TFV), in microdose and standard dosing regimens.
Study Design: We administered a microdose (100 μg) of C-labeled drug (ZDV or tenofovir disoproxil fumarate) with or without a standard unlabelled dose (300 mg) to healthy volunteers. Both the parent drug in plasma and the active metabolite, ZDV-triphosphate (ZDV-TP) or TFV-diphosphate (TFV-DP) in peripheral blood mononuclear cells (PBMCs) and CD4 cells were measured by accelerator mass spectrometry.
Results: The intracellular ZDV-TP concentration increased less than proportionally over the dose range studied (100 μg-300 mg), whereas the intracellular TFV-DP PKs were linear over the same dose range. ZDV-TP concentrations were lower in CD4 cells versus total PBMCs, whereas TFV-DP concentrations were not different in CD4 cells and PBMCs.
Conclusions: Our data were consistent with a rate-limiting step in the intracellular phosphorylation of ZDV but not TFV. Accelerator mass spectrometry shows promise for predicting the PK of active intracellular metabolites of nucleosides, but nonlinearity of PK may be seen with some drugs.
References: J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Nov 7;843(2):147-56. (PMID: 16828350)
J Clin Pharmacol. 2008 Nov;48(11):1282-8. (PMID: 18779377)
Clin Pharmacokinet. 2004;43(9):595-612. (PMID: 15217303)
Antimicrob Agents Chemother. 1998 Jul;42(7):1568-73. (PMID: 9660984)
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):406-11. (PMID: 16010161)
J Antimicrob Chemother. 2004 Dec;54(6):982-90. (PMID: 15537695)
Antimicrob Agents Chemother. 2011 Nov;55(11):5294-9. (PMID: 21896913)
Antimicrob Agents Chemother. 1998 Mar;42(3):612-7. (PMID: 9517941)
Nat Med. 1997 Aug;3(8):922-4. (PMID: 9256287)
Clin Cancer Res. 2007 Jul 15;13(14):4164-9. (PMID: 17634544)
PLoS One. 2010 Jul 01;5(7):e11409. (PMID: 20625386)
Antivir Ther. 2006;11(3):377-84. (PMID: 16759055)
Adv Drug Deliv Rev. 2011 Jun 19;63(7):503-10. (PMID: 21251940)
Anal Chem. 2011 Jul 15;83(14):5607-16. (PMID: 21627104)
Clin Pharmacol Ther. 2006 Sep;80(3):203-15. (PMID: 16952487)
Anal Chem. 2004 Jan 15;76(2):328-34. (PMID: 14719879)
Pharmacogenet Genomics. 2011 Aug;21(8):495-505. (PMID: 21691256)
Sci Transl Med. 2011 Dec 7;3(112):112re4. (PMID: 22158861)
Nucleosides Nucleotides Nucleic Acids. 2009 Aug;28(8):776-92. (PMID: 20183617)
Clin Pharmacol Ther. 2011 Aug;90(2):263-70. (PMID: 21716273)
J Pharm Biomed Anal. 2011 Sep 10;56(2):390-401. (PMID: 21715120)
Clin Pharmacol Ther. 2010 Dec;88(6):796-800. (PMID: 20981003)
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):298-303. (PMID: 18398970)
J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):10-7. (PMID: 21937920)
AIDS. 2007 Sep 12;21(14):1849-54. (PMID: 17721092)
AIDS Patient Care STDS. 2011 Feb;25(2):63-71. (PMID: 21284497)
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):248-57. (PMID: 16412710)
Antivir Ther. 2004 Aug;9(4):519-28. (PMID: 15456083)
Pharm Res. 2011 Aug;28(8):1963-72. (PMID: 21472491)
Science. 2010 Sep 3;329(5996):1168-74. (PMID: 20643915)
Antimicrob Agents Chemother. 2006 Jul;50(7):2471-7. (PMID: 16801428)
Nucleosides Nucleotides Nucleic Acids. 2008 Apr;27(4):319-31. (PMID: 18404568)
معلومات مُعتمدة: UL1 RR025005 United States RR NCRR NIH HHS; UL1-RR025005 United States RR NCRR NIH HHS
المشرفين على المادة: 0 (Anti-HIV Agents)
0 (Carbon Radioisotopes)
0 (Dideoxynucleotides)
0 (Organophosphonates)
0 (Reverse Transcriptase Inhibitors)
0 (Thymine Nucleotides)
4B9XT59T7S (Zidovudine)
6RGF96R053 (zidovudine triphosphate)
99YXE507IL (Tenofovir)
JAC85A2161 (Adenine)
تواريخ الأحداث: Date Created: 20121129 Date Completed: 20130204 Latest Revision: 20211021
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC3509498
DOI: 10.1097/QAI.0b013e3182717c98
PMID: 23187888
قاعدة البيانات: MEDLINE
الوصف
تدمد:1944-7884
DOI:10.1097/QAI.0b013e3182717c98